BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28432010)

  • 1. Exposure to an enriched environment facilitates motor recovery and prevents short-term memory impairment and reduction of striatal BDNF in a progressive pharmacological model of parkinsonism in mice.
    Campêlo CLC; Santos JR; Silva AF; Dierschnabel AL; Pontes A; Cavalcante JS; Ribeiro AM; Silva RH
    Behav Brain Res; 2017 Jun; 328():138-148. PubMed ID: 28432010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive, motor and tyrosine hydroxylase temporal impairment in a model of parkinsonism induced by reserpine.
    Santos JR; Cunha JA; Dierschnabel AL; Campêlo CL; Leão AH; Silva AF; Engelberth RC; Izídio GS; Cavalcante JS; Abílio VC; Ribeiro AM; Silva RH
    Behav Brain Res; 2013 Sep; 253():68-77. PubMed ID: 23831411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sitagliptin rescues memory deficits in Parkinsonian rats via upregulating BDNF to prevent neuron and dendritic spine loss.
    Li J; Zhang S; Li C; Li M; Ma L
    Neurol Res; 2018 Sep; 40(9):736-743. PubMed ID: 29781786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvacrol prevents impairments in motor and neurochemical parameters in a model of progressive parkinsonism induced by reserpine.
    Lins LCRF; Souza MF; Bispo JMM; Gois AM; Melo TCS; Andrade RAS; Quintans-Junior LJ; Ribeiro AM; Silva RH; Santos JR; Marchioro M
    Brain Res Bull; 2018 May; 139():9-15. PubMed ID: 29378222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in the progressive model of parkinsonism induced by reserpine in rats.
    Bispo JMM; Melo JEC; Gois AM; Leal PC; Lins LCRF; Souza MF; Medeiros KAAL; Ribeiro AM; Silva RH; Marchioro M; Santos JR
    Behav Brain Res; 2019 May; 363():23-29. PubMed ID: 30690108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging accentuates decrease in tyrosine hydroxylase immunoreactivity associated with the increase in the motor impairment in a model of reserpine-induced parkinsonism.
    Melo JEC; Santos TFO; Santos RS; Franco HS; Monteiro MCN; Bispo JMM; Mendonça MS; Ribeiro AM; Silva RH; Gois AM; Marchioro M; Lins LCRF; Santos JR
    J Chem Neuroanat; 2022 Nov; 125():102162. PubMed ID: 36115503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of enriched environment following neonatal hypoxia-ischemia on behavior, BDNF and synaptophysin levels in rat hippocampus: Effect of combined treatment with G-CSF.
    Griva M; Lagoudaki R; Touloumi O; Nousiopoulou E; Karalis F; Georgiou T; Kokaraki G; Simeonidou C; Tata DA; Spandou E
    Brain Res; 2017 Jul; 1667():55-67. PubMed ID: 28495306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive and anxiety-like impairments accompanied by serotonergic ultrastructural and immunohistochemical alterations in early stages of parkinsonism.
    Leal PC; Bispo JMM; Lins LCRF; Souza MF; Gois AM; Moore C; Marchioro M; Ribeiro AM; Silva RH; Meshul CK; Santos JR
    Brain Res Bull; 2019 Mar; 146():213-223. PubMed ID: 30641120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
    Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
    Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen reduces BDNF level, but maintains dopaminergic cell density in the striatum of MPTP mouse model.
    Tripanichkul W; Gerdprasert O; Jaroensuppaperch EO
    Int J Neurosci; 2010 Jul; 120(7):489-95. PubMed ID: 20583901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
    Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deltamethrin Intranasal administration induces memory, emotional and tyrosine hydroxylase immunoreactivity alterations in rats.
    Souza MF; Freire MAM; Medeiros KAAL; Lins LCRF; Bispo JMM; Gois AM; Leal PC; Engelberth RCGJ; Ribeiro AM; Silva RH; Marchioro M; Santos JR
    Brain Res Bull; 2018 Sep; 142():297-303. PubMed ID: 30118749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of (-)-sesamin on motor and memory deficits in an MPTP-lesioned mouse model of Parkinson's disease treated with l-DOPA.
    Zhao TT; Shin KS; Kim KS; Park HJ; Kim HJ; Lee KE; Lee MK
    Neuroscience; 2016 Dec; 339():644-654. PubMed ID: 27789382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the mesocorticolimbic pathway after low dose reserpine-treatment in Wistar and Spontaneously Hypertensive Rats (SHR): Implications for cognitive deficits in a progressive animal model for Parkinson's disease.
    Leão AHFF; Meurer YSR; Freitas TA; Medeiros AM; Abílio VC; Izídio GS; Conceição IM; Ribeiro AM; Silva RH
    Behav Brain Res; 2021 Jul; 410():113349. PubMed ID: 33971246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep deprivation induces late deleterious effects in a pharmacological model of Parkinsonism.
    Lopes-Silva LB; Cunha DMG; Lima AC; Bioni VS; Gonçalves N; Kurita JPF; Wuo-Silva R; Silva RH
    Exp Brain Res; 2024 May; 242(5):1175-1190. PubMed ID: 38499659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model.
    Bousquet M; Gibrat C; Saint-Pierre M; Julien C; Calon F; Cicchetti F
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1401-8. PubMed ID: 19632286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early enriched housing results in partial recovery of memory deficits in female, but not in male, rats after neonatal hypoxia-ischemia.
    Pereira LO; Strapasson AC; Nabinger PM; Achaval M; Netto CA
    Brain Res; 2008 Jul; 1218():257-66. PubMed ID: 18514167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An enriched environment ameliorates memory impairments in PACAP-deficient mice.
    Takuma K; Maeda Y; Ago Y; Ishihama T; Takemoto K; Nakagawa A; Shintani N; Hashimoto H; Baba A; Matsuda T
    Behav Brain Res; 2014 Oct; 272():269-78. PubMed ID: 25014004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease.
    Fernandes VS; Santos JR; Leão AH; Medeiros AM; Melo TG; Izídio GS; Cabral A; Ribeiro RA; Abílio VC; Ribeiro AM; Silva RH
    Behav Brain Res; 2012 May; 231(1):154-63. PubMed ID: 22446059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway.
    Zhu G; Li J; He L; Wang X; Hong X
    Br J Pharmacol; 2015 May; 172(9):2354-68. PubMed ID: 25560396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.